Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04529044
Title 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.